Retraction Note to: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy (31P-MRS)

[1]  Jimmy D Bell,et al.  In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. , 2008, Liver.

[2]  W. Lau,et al.  Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study , 2002, Gut.

[3]  Jimmy D Bell,et al.  In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts , 1998, Gut.

[4]  J. Squifflet,et al.  Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group , 1997 .

[5]  Jimmy D Bell,et al.  Cirrhosis of the human liver: an in vitro 31P nuclear magnetic resonance study. , 1995, Biochimica et biophysica acta.

[6]  D. Menon,et al.  Effect of functional grade and etiology on in vivo hepatic phosphorus‐31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances , 1995, Hepatology.

[7]  R. Rubin,et al.  Clinicopathologic features of late hepatic dysfunction in orthotopic liver transplants. , 1993, Human pathology.

[8]  R. Griffiths,et al.  An in vivo 31P MRS study of patients with liver cirrhosis: Progress towards a non‐invasive assessment of disease severity , 1993, NMR in biomedicine.

[9]  J. Ruíz-Cabello,et al.  Phospholipid metabolites as indicators of cancer cell function , 1992, NMR in biomedicine.

[10]  G. Radda,et al.  Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by 31P-NMR. , 1992, Biochimica et biophysica acta.

[11]  R. Lenkinski,et al.  Integrated magnetic resonance imaging and phosphorus spectroscopy of soft tissue tumors , 1991, Cancer.

[12]  K. Batts,et al.  Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution. , 1991, Transplantation proceedings.

[13]  G K Radda,et al.  Study of human liver disease with P-31 magnetic resonance spectroscopy. , 1990, Gut.

[14]  G. Radda,et al.  Phospholipid bilayer contribution to 31P NMR spectra in vivo , 1989, Magnetic resonance in medicine.

[15]  T. Ng,et al.  Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. , 1989, Radiology.

[16]  David Hilton-Jones,et al.  BIOCHEMICAL INVESTIGATION OF HUMAN TUMOURS IN VIVO WITH PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPY , 1986, The Lancet.

[17]  G. Radda,et al.  Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. , 1986, The British journal of radiology.

[18]  G. Radda,et al.  The metabolic state of the rat liver in vivo measured by 31P-NMR spectroscopy. , 1986, Biochimica et biophysica acta.

[19]  R. Wiesner,et al.  Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. , 1993, Mayo Clinic proceedings.